These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 17093103
1. Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production. Lin H, Cheung SW, Nesin M, Cassileth BR, Cunningham-Rundles S. Clin Vaccine Immunol; 2007 Jan; 14(1):21-7. PubMed ID: 17093103 [Abstract] [Full Text] [Related]
2. Maitake beta-glucan enhances umbilical cord blood stem cell transplantation in the NOD/SCID mouse. Lin H, De Stanchina E, Zhou XK, She Y, Hoang D, Cheung SW, Cassileth B, Cunningham-Rundles S. Exp Biol Med (Maywood); 2009 Mar; 234(3):342-53. PubMed ID: 19144872 [Abstract] [Full Text] [Related]
3. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Lin H, She YH, Cassileth BR, Sirotnak F, Cunningham Rundles S. Int Immunopharmacol; 2004 Jan; 4(1):91-9. PubMed ID: 14975363 [Abstract] [Full Text] [Related]
4. Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity. Lin H, de Stanchina E, Zhou XK, Hong F, Seidman A, Fornier M, Xiao WL, Kennelly EJ, Wesa K, Cassileth BR, Cunningham-Rundles S. Cancer Immunol Immunother; 2010 Jun; 59(6):885-97. PubMed ID: 20140432 [Abstract] [Full Text] [Related]
5. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium. De Bruyn C, Delforge A, Bron D, Ley P, de Hemptinne D, Stryckmans P. Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580 [Abstract] [Full Text] [Related]
6. Maitake beta-glucan enhances granulopoiesis and mobilization of granulocytes by increasing G-CSF production and modulating CXCR4/SDF-1 expression. Ito K, Masuda Y, Yamasaki Y, Yokota Y, Nanba H. Int Immunopharmacol; 2009 Sep; 9(10):1189-96. PubMed ID: 19573626 [Abstract] [Full Text] [Related]
7. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors. Ottmann OG, Abboud M, Welte K, Souza LM, Pelus LM. Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933 [Abstract] [Full Text] [Related]
8. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells. Bedford Russell AR, Davies EG, Gibson FM, Gordon-Smith EC. Pediatr Res; 1995 May; 37(5):630-3. PubMed ID: 7541523 [Abstract] [Full Text] [Related]
9. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored. Ruggieri L, Heimfeld S, Broxmeyer HE. Blood Cells; 1994 May; 20(2-3):436-54. PubMed ID: 7538350 [Abstract] [Full Text] [Related]
10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S. Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [Abstract] [Full Text] [Related]
15. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Traycoff CM, Abboud MR, Laver J, Brandt JE, Hoffman R, Law P, Ishizawa L, Srour EF. Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862 [Abstract] [Full Text] [Related]
16. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats. Iguchi K, Inoue S, Kumar A. Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109 [Abstract] [Full Text] [Related]
17. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice. Drize N, Chertkov J, Samoilina N, Zander A. Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232 [Abstract] [Full Text] [Related]
18. IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow. van de Ven C, Ishizawa L, Law P, Cairo MS. Exp Hematol; 1995 Nov; 23(12):1289-95. PubMed ID: 7589284 [Abstract] [Full Text] [Related]
19. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood. Van Zant G, Rummel SA, Koller MR, Larson DB, Drubachevsky I, Palsson M, Emerson SG. Blood Cells; 1994 Nov; 20(2-3):482-90; discussion 491. PubMed ID: 7538353 [Abstract] [Full Text] [Related]
20. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan. Patchen ML, Vaudrain T, Correira H, Martin T, Reese D. Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381 [Abstract] [Full Text] [Related] Page: [Next] [New Search]